Search

everythinglearnresearchcommunity

for

Search:↓

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Finasteride's polymorphic form affects capsule quality and drug effect, requiring strict control.

New antiscarring strategies show promise, including drugs, stem cells, and improved surgical techniques.

PCOS is a major cause of infertility and requires personalized treatment.

Viral warts are common in children, so prevention against HPV is important.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Gonadal biopsy is the best method to diagnose gonadal dysgenesis.

Smaller finasteride particles increase effectiveness in treating hair loss.

Skin health and diseases are closely linked to metabolic processes.

The document concludes that validated methods are needed to ensure the quality of fluconazole drugs and that new antifungal medications are necessary due to safety and resistance concerns.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Pregnancy can cause unique skin issues, some of which may risk the mother and baby's health and need careful treatment.

Researchers found a new genetic mutation causing a rare hair loss condition in the first Japanese child studied.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

The research provides a gene-based framework for hair biology, highlighting the Hippo pathway's importance and suggesting links between hair disorders, cancer pathways, and the immune system.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Researchers created a model to understand heart aging, highlighting the role of microRNAs and identifying key genes and pathways involved.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.